SINGAPORE, Jan 9 (Reuters) - Gene Solutions said on Thursday that Singapore-headquartered August Global Partners will invest in the biotech company through a proprietary funding round.
The Ho Chi Minh City-headquartered company did not disclose financial details in its statement. Gene Solutions said August Global Partners will assist it in enhancing the performance of its oncology services.
(Reporting by Yantoultra Ngui; Editing by Jan Harvey)
((Yantoultra.Ngui@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.